Veidekke

Veidekke ASA: To construct new research and development building in Mölndal

Veidekke's Swedish subsidiary BRA Bygg has been contracted to build new premises

for FUJIREBIO in GoCo Health Innovation City, a health innovation cluster

located in Mölndal, south of Gothenburg. The collaborative agreement with GoCo

Health Innovation City has an estimated value of SEK 185 million.

As the first building on the block, the 7,800 m[2] newbuild will be an important

cog in the wheel of further development of the area. The building, scheduled for

completion in the summer of 2021, will contain premises for research, production

and development of analytical methods for cancer diagnostics.

"Excellent collaboration with the client and user has enabled us to optimise

construction for completion of the building as early as summer 2021," says

Magnus Andersson of BRA Bygg.

Veidekke's subsidiary BRA Bygg (Billström Riemer Andersson AB), located in

Gothenburg, Sweden, has 285 employees and annual turnover of SEK 2.1 billion.

For more information, contact:

Magnus Andersson, dept. manageger BRA Bygg AB, ph. +46 031 89 44 03,

Mats Nyström, CEO Veidekke Sweden, ph. +46 705 37 12 60

Veidekke press photos (https://veidekke.fotoware.cloud/fotoweb/archives/5028

-Pressebilder-Veidekke/)

Subscribe to notices from Veidekke (http://veidekke.com/no/borsmeldinger/abonner

-pa-meldinger/)

Veidekke is one of Scandinavia's largest construction and property development

companies. The company undertakes all types of building construction and civil

engineering contracts, develops residential projects, maintains roads, and

produces asphalt and aggregates. The company is known for its involvement and

local knowledge. Its annual turnover is NOK 39 billion, and half of its 8,600

employees own shares in the company. Veidekke is listed on the Oslo Stock

Exchange and has always posted a profit since it was founded in 1936.

AI Terminal